Intravenous Methylprednisolone Pulses in Hospitalised Patients with Severe COVID-19 Pneumonia: A Double-Blind, Randomised, Placebo-Controlled Trial

In this multicentre, randomised, double-blind, placebo-controlled trial, 304 hospitalised patients with COVID-19 pneumonia were randomised to receive 1 g of methylprednisolone intravenously for three consecutive days or placebo in addition to standard dexamethasone.